Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Long-Term Deferred Tax (2016 - 2025)

Integra Lifesciences Holdings' Long-Term Deferred Tax history spans 17 years, with the latest figure at $109.7 million for Q3 2025.

  • For Q3 2025, Long-Term Deferred Tax rose 124.23% year-over-year to $109.7 million; the TTM value through Sep 2025 reached $109.7 million, up 124.23%, while the annual FY2024 figure was $34.9 million, 24.21% down from the prior year.
  • Long-Term Deferred Tax for Q3 2025 was $109.7 million at Integra Lifesciences Holdings, up from $102.9 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $109.7 million in Q3 2025 and bottomed at $34.2 million in Q1 2024.
  • The 5-year median for Long-Term Deferred Tax is $51.8 million (2022), against an average of $58.9 million.
  • The largest annual shift saw Long-Term Deferred Tax surged 3102.83% in 2021 before it tumbled 43.61% in 2022.
  • A 5-year view of Long-Term Deferred Tax shows it stood at $57.0 million in 2021, then decreased by 19.24% to $46.0 million in 2022, then increased by 0.19% to $46.1 million in 2023, then fell by 24.21% to $34.9 million in 2024, then surged by 214.2% to $109.7 million in 2025.
  • Per Business Quant, the three most recent readings for IART's Long-Term Deferred Tax are $109.7 million (Q3 2025), $102.9 million (Q2 2025), and $38.0 million (Q1 2025).